Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2016 Earnings

11FebConfirmed

Q2 2015

Q3 2015

Q4 2015

Q1 2016

-4.27

-3.47

-2.67

-1.87

Details

Expected EPS

-3.826848

Actual EPS

-4.265341

Surprise EPS

-0.44

Surprise Percent

+11.46%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.265341 per share for Q1 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.